The Gross Law Firm Notifies Shareholders of Organon & Co.(OGN) of a Class Action Lawsuit and an Upcoming Deadline

1. Gross Law Firm issues notice to OGN shareholders regarding possible legal action. 2. Allegations include misleading statements about capital allocation and dividend priorities. 3. Stock price fell over 27% following news of a substantial dividend cut. 4. Shareholders encouraged to register for possible lead plaintiff appointment. 5. Class action deadline for lead plaintiff registration is July 22, 2025.

Legal

90

5m saved

Insight

Article

FAQ

Why Very Bearish?

The significant loss in stock price due to misleading information showcases potential for further decline; similar past examples show investor sentiment can deteriorate rapidly under such circumstances.

How important is it?

Given the substantial price drop related to alleged misinformation, this news is crucial for potential investor decisions.

Why Short Term?

Immediate market reactions are expected due to fear of worsening financial maneuvers; past instances of legal actions have led to fluctuating prices.

Related Companies

DERM PFE ABT

NEW YORK, June 5, 2025 /PRNewswire/ --

The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN).

Shareholders who purchased shares of OGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=151580&from=4

CLASS PERIOD:

October 31, 2024 to April 30, 2025

ALLEGATIONS:

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Organon's priorities, particularly, related to capital allocation through quarterly dividends. Notably, defendants concealed the high priority of Organon's debt reduction strategy following the Company's acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend. Following this news, the price of Organon's common stock declined dramatically. From a closing market price of $12.93 per share on April 30, 2025, Organon's stock price fell to $9.45 per share on May 1, 2025, a decline of more than 27% in the span of just a single day.

DEADLINE:

July 22, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=151580&from=4

NEXT STEPS FOR SHAREHOLDERS:

Once you register as a shareholder who purchased shares of OGN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is July 22, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM?

The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: info@grosslawfirm.com
Phone: (646) 453-8903

SOURCE The Gross Law Firm